BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,105 | -41.9% | 6,839 | -29.9% | 0.01% | -37.5% |
| Q2 2023 | $444,482 | +95900.4% | 9,756 | -14.5% | 0.02% | -11.1% |
| Q1 2023 | $463 | -32.6% | 11,417 | -15.3% | 0.02% | -33.3% |
| Q4 2022 | $687 | -99.9% | 13,479 | -10.4% | 0.03% | -22.9% |
| Q3 2022 | $810,000 | -19.5% | 15,041 | -4.0% | 0.04% | -14.6% |
| Q2 2022 | $1,006,000 | +232.0% | 15,662 | +300.6% | 0.04% | +141.2% |
| Q1 2022 | $303,000 | -4.7% | 3,910 | +5.5% | 0.02% | 0.0% |
| Q4 2021 | $318,000 | +13.2% | 3,705 | +5.7% | 0.02% | -5.6% |
| Q3 2021 | $281,000 | -0.7% | 3,505 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $283,000 | +33.5% | 3,505 | +39.9% | 0.02% | +28.6% |
| Q1 2021 | $212,000 | -52.8% | 2,505 | -52.0% | 0.01% | -65.0% |
| Q2 2020 | $449,000 | +2.5% | 5,221 | -3.2% | 0.04% | -14.9% |
| Q1 2020 | $438,000 | -3.7% | 5,394 | -0.7% | 0.05% | +20.5% |
| Q4 2019 | $455,000 | -22.2% | 5,434 | -18.7% | 0.04% | -26.4% |
| Q3 2019 | $585,000 | +6.9% | 6,684 | 0.0% | 0.05% | +3.9% |
| Q2 2019 | $547,000 | +0.6% | 6,684 | 0.0% | 0.05% | -3.8% |
| Q1 2019 | $544,000 | +22.5% | 6,684 | -0.9% | 0.05% | +8.2% |
| Q4 2018 | $444,000 | -10.3% | 6,744 | +5.1% | 0.05% | -3.9% |
| Q3 2018 | $495,000 | -0.2% | 6,416 | -4.4% | 0.05% | -7.3% |
| Q2 2018 | $496,000 | +7.6% | 6,711 | -5.2% | 0.06% | +7.8% |
| Q1 2018 | $461,000 | +0.9% | 7,078 | 0.0% | 0.05% | +2.0% |
| Q4 2017 | $457,000 | +2.7% | 7,078 | 0.0% | 0.05% | -3.8% |
| Q3 2017 | $445,000 | -7.9% | 7,078 | -11.3% | 0.05% | -10.3% |
| Q2 2017 | $483,000 | +12.3% | 7,978 | -3.8% | 0.06% | +7.4% |
| Q1 2017 | $430,000 | +16.8% | 8,291 | 0.0% | 0.05% | +12.5% |
| Q4 2016 | $368,000 | +54.6% | 8,291 | +66.1% | 0.05% | +50.0% |
| Q3 2016 | $238,000 | +14.4% | 4,991 | +8.7% | 0.03% | +14.3% |
| Q2 2016 | $208,000 | -34.0% | 4,591 | +2.1% | 0.03% | -37.8% |
| Q2 2015 | $315,000 | -6.5% | 4,496 | -8.6% | 0.04% | -6.2% |
| Q1 2015 | $337,000 | +5.6% | 4,921 | +12.9% | 0.05% | +6.7% |
| Q4 2014 | $319,000 | +1.9% | 4,357 | 0.0% | 0.04% | -4.3% |
| Q3 2014 | $313,000 | +11.4% | 4,357 | +12.1% | 0.05% | +17.5% |
| Q2 2014 | $281,000 | -2.1% | 3,887 | -0.6% | 0.04% | -4.8% |
| Q1 2014 | $287,000 | +5.9% | 3,910 | +0.4% | 0.04% | +5.0% |
| Q4 2013 | $271,000 | +34.8% | 3,895 | +27.0% | 0.04% | +25.0% |
| Q3 2013 | $201,000 | -13.7% | 3,066 | -8.9% | 0.03% | +23.1% |
| Q2 2013 | $233,000 | – | 3,366 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |